Platelet count increased in Tecfidera - how severe and when it was recovered? (a real world drug study)
Summary:
There is no report of severity or recovery of Platelet count increased by people who take Tecfidera yet.
What is Tecfidera?
Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.
What is Platelet Count Increased?
Platelet count increased is found to be associated with 956 drugs and 1,190 conditions by eHealthMe. Check the latest studies of Platelet count increased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
No report is found.
Do you take Tecfidera and have Platelet count increased?
Check whether Platelet count increased is associated with a drug or a conditionHow to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
How the study uses the data?
The study is based on dimethyl fumarate (the active ingredients of Tecfidera). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gallbladder Disease and drugs of ingredients of sunitinib malate - 3 seconds ago
- Abscess Jaw and drugs of ingredients of docetaxel - 5 seconds ago
- Revlimid and Reglan drug interactions for women aged 60+ - 5 seconds ago
- How effective is Arava for Arthritis? - 6 seconds ago
- Joint Range Of Motion Decreased and drugs of ingredients of melphalan hydrochloride - 7 seconds ago
- Tranxene and Isosorbide Mononitrate drug interactions for women aged 60+ - 10 seconds ago
- Laryngitis and drugs of ingredients of lenvatinib mesylate - 10 seconds ago
- Drug interactions of Nuvigil and Ondansetron - 11 seconds ago
- Drug interactions of Carafate and Multivitamin - 11 seconds ago
- Rickets and drugs of ingredients of levetiracetam - 12 seconds ago